Modified masaoka stage and size are independent prognostic predictors in thymoma and modified masaoka stage is superior to histopathologic classifications

Journal of Thoracic Oncology

Volumn 10, Issue 4, 2015, Pages 691-700

  Roden, Anja C ^a   Yi, Eunhee S ^a   Jenkins, Sarah M ^a   Edwards, Kelly K ^a   Donovan, Janis L ^a   Cassivi, Stephen D ^a   Marks, Randolph S ^a   Garces, Yolanda I ^a   Aubry, Marie Christine ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Bernatz classification; Modified Masaoka staging; Moran staging; Proposed Suster and Moran classification; WHO classification

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BERNATZ CLASSIFICATION; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED MASAOKA STAGE; OVERALL SURVIVAL; PATHOLOGIST; PREDICTION; PRIORITY JOURNAL; THYMOMA; TREATMENT DURATION; TUMOR INVASION; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION; CLASSIFICATION; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TRENDS; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYMOMA; THYMUS NEOPLASMS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84938293501     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000482     Document Type: Article

References (35)

1. Koga K, Matsuno Y, Noguchi M, A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994 44 359 367
2. Harnath T, Marx A, Ströbel P, Bölke E, Willers R, Gripp S, Thymoma-A clinico-pathological long-Term study with emphasis on histology and adjuvant radiotherapy dose. J Thorac Oncol 2012 7 1867 1871
3. Ruffini E, Filosso PL, Mossetti C, Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: A single-centre experience. Eur J Cardiothorac Surg 2011 40 146 153
4. Demirci S, Turhan K, Ozsan N, Prognostic factors for survival in patients with thymic epithelial tumors. Thorac Cardiovasc Surg 2011 59 153 157
5. Filosso PL, Venuta F, Oliaro A, Thymoma and inter-relationships between clinical variables: A multicentre study in 537 patients. Eur J Cardiothorac Surg 2014 45 1020 1027
6. Moran CA, Walsh G, Suster S, Kaiser L, Thymomas II: A clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol 2012 137 451 461
7. Zucali PA, Di Tommaso L, Petrini I, Reproducibility of the WHO classification of thymomas: Practical implications. Lung Cancer 2013 79 236 241
8. Verghese ET, den Bakker MA, Campbell A, Interobserver variation in the classification of thymic tumours-A multicentre study using the WHO classification system. Histopathology 2008 53 218 223
9. Roden AC, Yi ES, Jenkins SM, Reproducibility of three histological classifications and three staging systems for thymic epithelial neoplasms and its effect on prognosis. Am J Surg Pathol 2015
10. Rieker RJ, Hoegel J, Morresi-Hauf A, Histologic classification of thymic epithelial tumors: Comparison of established classification schemes. Int J Cancer 2002 98 900 906
11. Mueller-Hermelink HK, Engel P, Kuo TT, Travis WD, Brambilla E, Mueller-Hermelink HK, Tumours of the thymus. WHO Classification of Tumours Pathology & Genetics Tumours of the Lung, Pleura, Thymus and Heart 2004 Lyon CC Harris IARC Press Pp. 146 181
12. Bernatz PE, Harrison EG, Clagett OT, Thymoma: A clinicopathologic study. J Thorac Cardiovasc Surg 1961 42 424 444
13. Suster S, Moran CA, Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol 1999 111 826 833
14. Harrell FE Jr, Lee KL, Mark DB, Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996 15 361 387
15. Nakagawa K, Asamura H, Matsuno Y, Thymoma: A clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003 126 1134 1140
16. Rena O, Papalia E, Maggi G, World Health Organization histologic classification: An independent prognostic factor in resected thymomas. Lung Cancer 2005 50 59 66
17. Wilkins KB, Sheikh E, Green R, Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 1999 230 562 572; discussion 572
18. Kim DJ, Yang WI, Choi SS, Kim KD, Chung KY, Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: A clinicopathologic study of 108 patients and literature review. Chest 2005 127 755 761
19. Kondo K, Yoshizawa K, Tsuyuguchi M, WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 2004 77 1183 1188
20. Rea F, Marulli G, Girardi R, Long-Term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg 2004 26 412 418
21. Sperling B, Marschall J, Kennedy R, Pahwa P, Chibbar R, Thymoma: A review of the clinical and pathological findings in 65 cases. Can J Surg 2003 46 37 42
22. Chalabreysse L, Roy P, Cordier JF, Loire R, Gamondes JP, Thivolet-Bejui F, Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: A retrospective study of 90 tumors. Am J Surg Pathol 2002 26 1605 1611
23. Detterbeck FC, Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 2006 81 2328 2334
24. Mariano C, Ionescu DN, Cheung WY, Thymoma: A population-based study of the management and outcomes for the province of British Columbia. J Thorac Oncol 2013 8 109 117
25. Sakakura N, Tateyama H, Nakamura S, Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: Note for thoracic clinicians. Gen Thorac Cardiovasc Surg 2013 61 89 95
26. Chen G, Marx A, Chen WH, New WHO histologic classification predicts prognosis of thymic epithelial tumors: A clinicopathologic study of 200 thymoma cases from China. Cancer 2002 95 420 429
27. Okumura M, Ohta M, Tateyama H, The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: A clinical study of 273 patients. Cancer 2002 94 624 632
28. Nonaka D, Rosai J, Is there a spectrum of cytologic atypia in type a thymomas analogous to that seen in type B thymomas? A pilot study of 13 cases. Am J Surg Pathol 2012 36 889 894
29. Masaoka A, Staging system of thymoma. J Thorac Oncol 2010 5 S304 S312
30. Ruffini E, Detterbeck F, Van Raemdonck D, European Association of Thoracic Surgeons (ESTS) Thymic Working Group Tumours of the thymus: A cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg 2014 46 361 368
31. th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014 9 S65 S72
32. Wright CD, Wain JC, Wong DR, Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 2005 130 1413 1421
33. Bae MK, Lee SK, Kim HY, Recurrence after thymoma resection according to the extent of the resection. J Cardiothorac Surg 2014 9 51
34. Safieddine N, Liu G, Cuningham K, Prognostic factors for cure, recurrence and long-Term survival after surgical resection of thymoma. J Thorac Oncol 2014 9 1018 1022
35. Aydiner A, Toker A, Sen F, Association of clinical and pathological variables with survival in thymoma. Med Oncol 2012 29 2221 2228